[go: up one dir, main page]

PH12015500834A1 - Oral composition - Google Patents

Oral composition

Info

Publication number
PH12015500834A1
PH12015500834A1 PH12015500834A PH12015500834A PH12015500834A1 PH 12015500834 A1 PH12015500834 A1 PH 12015500834A1 PH 12015500834 A PH12015500834 A PH 12015500834A PH 12015500834 A PH12015500834 A PH 12015500834A PH 12015500834 A1 PH12015500834 A1 PH 12015500834A1
Authority
PH
Philippines
Prior art keywords
oral composition
oxo
carboxylic acid
perioral
azepanyl
Prior art date
Application number
PH12015500834A
Other versions
PH12015500834B1 (en
Inventor
Fujikawa Haruhiko
Inoue Shimako
Asakuma Hiroki
Oniki Takayuki
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of PH12015500834A1 publication Critical patent/PH12015500834A1/en
Publication of PH12015500834B1 publication Critical patent/PH12015500834B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Provided is an oral composition having high perioral disease-preventing effect by removing, for a long period of time, active oxygen in cells constituting gingiva. An oral composition containing: (A) a lactam compound and/or a salt thereof having an acidic group selected from the group consisting of pyrrolidone carboxylic acid, 6-oxo-2-piperidine carboxylic acid, and 3-(2-oxo-1-azepanyl) propanoic acid; and (B) an antioxidant.
PH12015500834A 2012-11-08 2015-04-16 Oral composition PH12015500834B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012246674 2012-11-08
PCT/JP2013/079743 WO2014073490A1 (en) 2012-11-08 2013-11-01 Oral composition

Publications (2)

Publication Number Publication Date
PH12015500834A1 true PH12015500834A1 (en) 2015-06-22
PH12015500834B1 PH12015500834B1 (en) 2019-06-28

Family

ID=50684596

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015500834A PH12015500834B1 (en) 2012-11-08 2015-04-16 Oral composition

Country Status (6)

Country Link
JP (1) JP6243849B2 (en)
KR (1) KR102076611B1 (en)
CN (1) CN104780901B (en)
MY (1) MY184460A (en)
PH (1) PH12015500834B1 (en)
WO (1) WO2014073490A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6721968B2 (en) * 2015-11-20 2020-07-15 花王株式会社 Bubble gingival retraction prevention and improvement agent
JP6615007B2 (en) * 2016-03-03 2019-12-04 ライオン株式会社 Oral composition
CN106420556A (en) * 2016-09-27 2017-02-22 黄红光 Toothpaste containing bio-additives and preparation method of toothpaste
JP6914654B2 (en) * 2016-12-28 2021-08-04 ライオン株式会社 Oral composition
CN111759788A (en) * 2020-07-27 2020-10-13 浙江爱尚日用品有限公司 Toothpaste for preventing and treating dental ulcer
CN112515049A (en) * 2020-11-09 2021-03-19 南京未来宠物产业研究院有限公司 Application of astaxanthin in preparation of functional pet food
US20250205266A1 (en) * 2022-03-14 2025-06-26 Mirailab Bioscience Inc. Agent for oral diseases
CN116251048B (en) * 2023-03-30 2024-07-09 水羊化妆品制造有限公司 Composition for improving stability and efficacy of ascorbic acid, preparation method and skin care product

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2814549B2 (en) 1989-05-08 1998-10-22 ライオン株式会社 Oral composition
JP2597735B2 (en) 1990-06-21 1997-04-09 川崎製鉄株式会社 Seismic isolation device
JPH1053515A (en) 1996-08-09 1998-02-24 Ajinomoto Co Inc Skin lotion
BR0014778A (en) * 1999-10-19 2002-07-16 Procter & Gamble Antimicrobial Composition, Processes for Killing Bacteria, for Disabling Viruses, for Improving a Mammal's Global Health, for Reducing Absence of Persons, Use of Composition, Antimicrobial Product, and Personal Antimicrobial Treatment Set
US20040202899A1 (en) 2002-06-05 2004-10-14 Toshio Komuro Antithrombogenic platiniferous ceramic composition and article containing the same
JP2004083543A (en) 2002-08-27 2004-03-18 Lion Corp Oral composition containing ascorbic acid derivative
JPWO2004052385A1 (en) * 2002-12-06 2006-04-06 サンスター株式会社 Composition containing green-yellow vegetable and light-colored vegetable
US20100158820A1 (en) * 2003-06-20 2010-06-24 Bailey Donald W Xylitol dental maintenance system
FR2871060B1 (en) * 2004-06-08 2008-07-11 Ajinomoto Kk SUPPRESSOR AGENT FOR INFLAMMATION AND METHOD USING THE SAME
JP2006045491A (en) * 2004-07-01 2006-02-16 Erubu:Kk Functional material, method for producing functional material, functional member and environment modification apparatus using the functional material
CN101057819A (en) * 2006-04-21 2007-10-24 陈晓刚 Nutrition recuperating shampoo with plant keratin
CN101057953A (en) * 2006-04-21 2007-10-24 陈祖辉 Multi-target cooperative control preparation for treating virus infectious disease
JP5223083B2 (en) 2006-06-21 2013-06-26 国立大学法人京都大学 Angiogenesis inhibitor
JP2009196987A (en) 2008-01-23 2009-09-03 Kao Corp Tooth paste composition for periodontal disease
CN102802602B (en) * 2009-06-08 2014-08-06 狮王株式会社 oral composition
JP2011140454A (en) * 2010-01-06 2011-07-21 Sunstar Inc Composition for oral cavity
JP5644591B2 (en) * 2011-03-03 2014-12-24 ライオン株式会社 Oral composition and inhibitor of active oxygen injury of gingival fibroblasts

Also Published As

Publication number Publication date
CN104780901A (en) 2015-07-15
CN104780901B (en) 2019-04-26
WO2014073490A1 (en) 2014-05-15
JP6243849B2 (en) 2017-12-06
PH12015500834B1 (en) 2019-06-28
JPWO2014073490A1 (en) 2016-09-08
KR20150081249A (en) 2015-07-13
KR102076611B1 (en) 2020-02-12
MY184460A (en) 2021-04-01

Similar Documents

Publication Publication Date Title
PH12015500834A1 (en) Oral composition
EA201270216A1 (en) PHARMACEUTICAL COMPOSITION
WO2014014835A3 (en) Criystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
MX2014002014A (en) Formulations, use thereof as or to produce dishwashing detergents, and production thereof.
MY174149A (en) Composition for oral cavity
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
PH12014502744A1 (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
EP3949973A3 (en) Compositions and methods for treating depression
IN2015DN03991A (en)
PH12014502567A1 (en) Piperidine derivatives for gpr119 agonist
PH12014501264A1 (en) Oral care compositions
PT2404502T (en) Compositions containing pyrrolidone carboxylic acid (pca) and metallic salts
EP2576576A4 (en) BISPHOSPHONIC HETEROCYCLYL-PYRIDINYL ACID, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION CONTAINING THE SAME, AND METHOD FOR USING THE SAME
EA201291431A1 (en) COMPOSITION FOR HAIR STORAGE
EA201170287A1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR STABILIZATION
SI2614057T1 (en) Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
IN2015DN00568A (en)
PH12015502211A1 (en) Oral composition
GEP20125680B (en) Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydra-zinium) ropionate esters and their use for 3-(2,2,2-rimethyl- hydrazinium) propionate dihydrate preparation
WO2012177075A3 (en) Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
TR201000689A1 (en) Solid dosage forms containing cefprozil.
EA201491734A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING RAZAGILINA SALTS
TR201009166A2 (en) Production method for cefdinir-containing pharmaceutical composition
HUE036037T2 (en) (3S, 3S ') 4,4'-Disulfandyl-bis (3-aminobutane-1-sulfonic acid), i.e., crystalline form of ABSD, L-lysine